Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Visual Outcomes, Patient Satisfaction and Spectacle Independence Evaluation of the Acrysof® IQ Vivity® Intraocular Lens Targeted for Emmetropia or Nanovision.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05464732
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:42.984278+00:00
Published At
2025-03-24T00:00:00+00:00
Record Updated At
2025-03-24
Results Posted At
2025-03-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Presbyopia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-03-24"
protocolSection.identificationModule.nctId
"NCT05464732"
protocolSection.identificationModule.officialTitle
"Visual Outcomes, Patient Satisfaction and Spectacle Independence Evaluation of the Acrysof\u00ae IQ Vivity\u00ae Intraocular Lens Targeted for Emmetropia or Nanovision."
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2025-03-24"

Study condition terms

  • Presbyopia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.